viru
entri
surfac
glycoprotein
ebola
viru
ebov
undergo
complex
set
transform
within
endosom
network
tool
studi
ebov
entri
limit
static
immunofluoresc
biochem
function
analysi
recent
articl
mbio
spenc
et
al
report
novel
livecellimag
method
track
transform
journey
ebov
real
time
j
spenc
b
kraus
e
mittler
r
k
jangra
k
chandran
mbio
http
assay
valid
known
mechan
ebov
entri
shed
light
novel
intricaci
direct
evid
support
hypothesi
fusion
rare
event
start
matur
earli
endosom
complet
late
endosom
occur
entir
niemannpick
posit
compart
studi
demonstr
lipid
mix
product
fusion
tempor
decoupl
differ
energet
barrier
proteasedepend
step
two
event
analysi
mechan
action
import
class
ebov
neutral
antibodi
zmapp
provid
direct
evid
antibodi
act
inhibit
membran
fusion
oblig
intracellular
parasit
virus
penetr
live
cell
order
replic
virus
gener
one
cell
surfac
receptor
attach
factor
viru
type
enter
cell
direct
fusion
plasma
membran
throughout
evolut
virus
develop
eleg
strategi
hijack
endosom
network
maze
tubular
vesicular
structur
eukaryot
cell
task
cellular
traffick
penetr
cell
deliv
genom
endosom
pick
cargo
plasma
membran
transport
cell
goal
deliv
cytoplasm
organel
rout
lysosom
graveyard
recycl
back
plasma
membran
endosom
undergo
matur
process
accompani
morpholog
physiochem
transform
includ
acidif
acquisit
variou
function
molecul
ebola
viru
ebov
util
dynam
endosom
environ
regul
complex
set
transform
envelop
glycoprotein
necessari
fusion
viral
endosom
membran
deliveri
viral
genom
host
cell
date
studi
ebov
entri
process
limit
static
immunofluoresc
imag
viru
particl
bulk
biochem
function
analysi
howev
recent
articl
mbio
spenc
et
al
report
livecel
imag
assay
track
real
time
transform
journey
ebov
cell
surfac
endosom
network
directli
detect
membran
fusion
step
entri
report
along
similar
assay
publish
recent
simmon
et
al
could
lead
deeper
understand
entri
mechan
filovirus
could
ultim
help
effort
devis
better
treatment
strategi
deadli
virus
trimer
glycoprotein
gp
spike
consist
receptorbind
subunit
fusion
subunit
mediat
filoviru
entri
host
cell
entri
process
fig
begin
incomplet
understood
interact
gp
cell
surfac
attach
factor
deliv
viru
particl
endosom
via
macropinocytosi
within
endosom
gp
undergo
seri
transform
includ
proteolyt
cleavag
aciddepend
conform
chang
overcom
high
energet
barrier
fusion
proteolysi
gp
acid
environ
endosom
resid
cellular
enzym
call
cystein
cathepsin
remov
larg
portion
subunit
unmask
previous
buri
receptorbind
site
rb
leav
trimer
protein
consist
entir
core
rb
promin
expos
cleav
gp
gp
cl
interact
endosom
receptor
niemannpick
gp
cl
interact
posit
fusion
domain
interact
endosom
membran
trigger
viral
membran
fusion
enigmat
featur
filoviru
entri
mechan
ident
fusion
trigger
host
stimulu
induc
structur
rearrang
lead
viral
membran
fusion
gp
cl
interact
prerequisit
membran
fusion
may
suffici
structur
analysi
demonstr
intern
fusion
loop
ifl
ebov
gp
undergo
major
conform
chang
expos
acid
ph
lipid
bilay
conform
chang
may
contribut
initi
fusion
addit
low
ph
factor
cathepsin
may
requir
gp
trigger
suggest
observ
fusion
pseudotyp
virus
bear
gp
cl
inhibit
cathepsin
inhibitor
trigger
unwind
helic
structur
around
posit
ifl
top
trimer
next
endosom
membran
ifl
penetr
endosom
membran
collaps
prehairpin
intermedi
pull
togeth
viru
endosom
membran
lead
hemifus
follow
format
fusion
pore
postfus
sixhelix
bundl
structur
viru
deliv
content
pore
host
cytoplasm
directli
visual
filoviru
membran
fusion
process
spenc
et
al
util
lipophil
dye
label
envelop
recombin
vesicular
stomat
viru
rvsv
pseudotyp
ebov
gp
variou
format
fluoresc
particl
trace
travers
endosom
network
lipid
mix
viral
endosom
membranesan
initi
step
fusion
processwa
visual
rapid
increas
fluoresc
dequench
result
later
diffus
dye
detect
system
complement
genet
express
tag
visual
variou
endosom
marker
realtim
coloc
analysi
major
strength
strategi
employ
spenc
et
al
label
perform
purifi
rvsv
particl
rather
crude
supernat
label
particl
purifi
away
unincorpor
dye
dual
purif
afford
popul
viral
particl
uniformli
high
level
yield
strong
increas
fluoresc
upon
lipid
mix
featur
critic
detect
initi
fusion
gainoffunct
readout
rather
loss
fluoresc
studi
perform
livecel
assay
confirm
almost
everi
aspect
ebov
entri
previous
defin
static
populationbas
immunofluoresc
biochem
analysi
time
shed
new
light
aspect
entri
previous
unknown
underappreci
assay
confirm
ebov
entri
occur
acidifi
endosom
collect
data
larg
number
particl
author
abl
defin
halflif
ebov
entri
furthermor
paper
show
entri
process
highli
ineffici
small
fraction
particl
enter
cell
actual
go
initi
fusion
consist
report
high
ratio
particl
plaqueform
unit
genom
copi
number
filovirus
quantit
analysi
would
difficult
imposs
use
bulk
endocytosi
moreov
find
suggest
microscopybas
approach
fail
directli
measur
filoviru
membran
fusion
may
lead
mislead
conclus
sinc
viral
particl
intern
endosom
initi
product
infect
coloc
studi
use
fluoresc
label
endosom
marker
demonstr
virion
coloc
time
dequench
consist
two
recent
report
disagr
anoth
studi
suggest
membran
fusion
occur
endosom
lack
express
twopor
calcium
channel
tpc
howev
livecel
assay
tpc
inhibitor
tetrandrin
inhibit
lipid
mix
consist
role
tpc
ebov
entri
studi
also
show
viral
lipid
mix
occur
primarili
late
endosom
consist
previou
report
unexpectedli
lipid
mix
event
occur
endosom
compart
like
repres
matur
vesicl
transit
earli
late
endosom
interest
featur
assay
abil
uncoupl
lipid
mix
complet
membran
fusion
mention
specif
cathepsin
inhibitor
block
entri
rvsv
bear
gp
cl
interestingli
livecel
imag
perform
spenc
et
al
show
impact
lipid
mix
complet
block
product
fusion
data
suggest
may
addit
proteasedepend
step
initi
lipid
mix
product
fusion
lead
content
releas
futur
studi
reveal
specif
target
proteolyt
step
relat
mechan
fusion
assay
could
use
studi
mechan
action
entri
inhibitor
neutral
antibodi
bestcharacter
neutral
epitop
ebov
gp
conform
epitop
base
trimer
gp
consist
residu
n
terminu
antibodi
well
two
compon
zmapp
therapeut
antibodi
cocktail
bind
epitop
believ
block
fusion
lock
gp
prefus
conform
first
time
spenc
et
al
provid
direct
evid
live
cell
antibodi
inde
fulli
block
lipid
mix
precursor
product
fusion
consist
hypothesi
antibodi
lock
prefus
conform
bridg
bind
like
remov
flexibl
fusion
loop
undergo
conform
chang
need
insert
membran
interestingli
much
commentari
higher
concentr
neutral
antibodi
need
block
lipid
mix
viru
neutral
suggest
product
fusion
deliveri
genom
face
higher
energet
barrier
lipid
mix
possibl
process
requir
higher
number
gp
spike
engag
endosom
membran
demonstr
level
mechanist
detail
would
nearli
imposs
without
realtim
assay
membran
fusion
futur
would
interest
use
assay
examin
antibodi
target
type
epitop
rb
glycan
cap
impact
entri
process
recent
simmon
et
al
also
publish
similar
live
imag
assay
base
pseudotyp
retrovir
particl
label
work
also
recapitul
sever
featur
filoviru
entri
mechan
depend
acidifi
endosom
cystein
cathepsin
clearli
demonstr
viral
membran
fusion
occur
late
endosomeslysosom
howev
level
specif
label
viral
particl
assay
low
fluoresc
dequench
ie
lipid
mix
reproduc
monitor
hand
retrovirusbas
particl
gener
simmon
et
al
includ
gagmko
fusion
protein
releas
cytoplasm
upon
product
entri
abil
show
content
releas
major
strength
assay
abil
show
dequench
key
advantag
method
spenc
et
al
would
highli
desir
combin
two
featur
one
assay
would
allow
detail
realtim
studi
decoupl
process
lipid
mix
product
fusion
nearli
mechanist
studi
ebov
entri
perform
use
pseudotyp
virus
system
help
defin
mechan
ebov
entri
given
morpholog
differ
pseudotyp
authent
filament
viru
import
replic
find
use
authent
virus
condit
biosafeti
level
contain
livecellimag
assay
well
suit
purpos
envelop
readili
load
sever
facil
equip
sophist
imag
system
content
deliveri
could
monitor
use
recombin
ebolavirus
express
nucleocapsid
protein
fluoresc
tag
use
recent
describ
ebov
could
simplifi
assay
allow
perform
condit
driven
higher
frequenc
outbreak
zair
ebov
nearli
work
filoviru
entri
focus
particular
viru
import
rememb
biolog
filovirus
simpli
infer
ebov
consider
sequenc
diverg
glycoprotein
ebov
sudan
viru
sudv
bundibugyo
viru
bdbv
even
ebolavirus
marburg
virus
therefor
assum
mechan
entri
virus
ident
hope
excel
imag
assay
also
use
shed
light
mechan
entri
filovirus
